B.R.I.D.G.E. TO DATA® has been utilized in several published studies

and cited in relevant textbooks and presentations, as well as mentioned on some websites

  1. Carr MM, Schaefer EW, Schubart JR. Post-tonsillectomy outcomes in children with and without narcotics prescriptions. Ear, Nose & Throat Journal. 2021 Feb;100(2):124-9.
  2. Sturkenboom M, FAIR Catalogue sustainability: Technical workshop on real-world metadata for regulatory purposes. Virtual meeting, April 12, 2021.
  3. Pigeot I., Tahden M., Zampatis D., Watson D.J., Forssen U., Kollhorst B. (2021) Worldwide Availability of Pharmacoepidemiological Databases. In: Sturkenboom M., Schink T. (eds) Databases for Pharmacoepidemiological Research. Springer Series on Epidemiology and Public Health. Springer, Cham. 
  4. Dedman D, Cabecinha M, Williams R, Evans SJ, Bhaskaran K, Douglas IJ. Approaches for combining primary care electronic health record data from multiple sources: a systematic review of observational studies. BMJ open. 2020 Oct 1;10(10):e037405.
  5. Xia AD, Schaefer CP, Szende A, Jahn E, Hirst MJ. RWE framework: an interactive visual tool to support a real-world evidence study design. Drugs-real world outcomes. 2019 Dec;6(4):193-203.
  6. Etminan M, Sodhi M, Ganjizadeh-Zavareh S, Carleton B, Kezouh A, Brophy JM. Oral fluoroquinolones and risk of mitral and aortic regurgitation. Journal of the American College of Cardiology. 2019 Sep 17;74(11):1444-50.
  7. Xia A, Schaefer C, Szende A, Jahn E. Development of a real world evidence study design tool: RWE framework. Poster presented at: ISPOR Europe; 2018 Nov 10-14; Barcelona, Spain.
  8. Kava BR, Verbeek AE, Wruck JM, Gittelman M. Tamsulosin dispensation patterns in the United States: a real-world, longitudinal, population claims database analysis. Translational andrology and urology. 2019 Aug;8(4):329
  9. Galaznik A, Reich C, Klebanov G, Khoma Y, Allakhverdiiev E, Hather G, Shou Y. Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care. Cancer informatics. 2019 Mar;18:1176935119835538.
  10. Robinson DE, van Staa TP, Dennison EM, Cooper C, Dixon WG. The limitations of using simple definitions of glucocorticoid exposure to predict fracture risk: a cohort study. Bone. 2018 Dec 1;117:83-90.
  11. Cohan S, Smoot K, Kresa-Reahl K, Garland R, Yeh WS, Wu N, Watson C. Outcomes of stable multiple sclerosis patients staying on initial interferon beta therapy versus switching to another interferon beta therapy: a US claims database study. Advances in therapy. 2018 Nov;35(11):1894-904.
  12. Pacurariu A, Plueschke K, McGettigan P, Morales DR, Slattery J, Vogl D, Goedecke T, Kurz X, Cave A. Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation. BMJ open. 2018 Sep 1;8(9):e023090.
  13. Bergeron J, Doiron D, Marcon Y, Ferretti V, Fortier I. Fostering population-based cohort data discovery: The Maelstrom Research cataloguing toolkit. PloS one. 2018 Jul 24;13(7):e0200926.
  14. Silva LB, Trifan A., Oliveira JL. MONTRA: An agile architecture for data publishing and discovery. Computer Methods and Programs in Biomedicine. 2018 Jul;160:33-42.
  15. Camm AJ, Coleman CI, Larsen TB, Nielsen PB, Tamayo CS. Understanding the Value of Real-World Evidence: Focus on Stroke Prevention in Atrial Fibrillation with Rivaroxaban. Thromb Haemost. 2018 May;118(S 01):S45-S60.
  16. Sodhi M, Sheldon CA, Carleton B, Etminan M. Risk of Pseudotumor Cerebri Syndrome (PTCS) with hormonal contraceptive use. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2018 Feb 27;7(3):778-82.
  17. Chen Y, Zivkovic M, Wang T, Su S, Lee J, Bortnichak EA. A Systematic Review of Coding Systems Used in Pharmacoepidemiology and Database Research. Methods of Information in Medicine. 2018 Feb;57(1):1-42.
  18. Kathe N, Shah A, Said Q, Painter JT. DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study. Diabetes Therapy. 2018 Feb;9(1):141-51.
  19. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. Am Health Drug Benefits. 2018 Feb;11(1):12-21.
  20. Shah PS, McDonald SD, Barrett J, Synnes A, Robson K, Foster J, Pasquier JC, Joseph KS, Piedboeuf B, Lacaze-Masmonteil T, O'Brien K. The Canadian Preterm Birth Network: a study protocol for improving outcomes for preterm infants and their families. CMAJ open. 2018 Jan;6(1):E44.
  21. Goyat, R. The Impact of Comorbidities on Diabetes and Hypertension Co-Management and Healthcare Expenditures. 2018. Graduate Theses, Dissertations, and Problem Reports. 3752. (Graduate Thesis)
  22. Sodhi, M., Risk of acute angle closure glaucoma with triptan use in migraine patients : a nested case control study, T, University of British Columbia, 2018. (Graduate Thesis)
  23. Fortin Y, Crispo JA., Cohen D, Dahrouge S, McNair DS, Mattison DR, Krewski D. Association between multimorbidity and motor-vehicle accidents in persons with epilepsy. An Assessment of the Effect of Multimorbidity on Motor-Vehicle Accident Risk. 2017 Sep 25;270-310.
  24. Fortin Y, Crispo JA., Cohen D, McNair DS, Mattison DR, Krewski D. Optimal Look Back Period and Summary Method for Elixhauser Comorbidity Measures in a US Population-Based Electronic Health Record Database. An Assessment of the Effect of Multimorbidity on Motor-Vehicle Accident Risk. 2017 Sep 25;81-113.
  25. Fortin Y, Crispo JA., Cohen D, McNair DS, Mattison DR, Krewski D. External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality. PloS One. 2017 Mar 28;12(3):e0174379.
  26. Lopes P, Silva LB, Oliveira JL. Challenges and Opportunities for Exploring Patient-Level Data. Biomed Res Int. 2015;2015:150435.
  27. Dominique M, Azmi S, Reginald P, Verpillat P, Francois C. A review of accessibility of administrative healthcare databases in the Asia-Pacific region. Journal of Market Access & Health Policy. 2015 Jul 20;3:28076.
  28. Milea D, Azmi S, Reginald P, Verpillat P, Francois C. A review of accessibility of administrative healthcare databases in the Asia-Pacific region. J Mark Access Health Policy. 2015 Jul 20;3. doi: 10.3402/jmahp.v3.28076. PMID: 27123180; PMCID: PMC4802693.
  29. Scales CD Jr, Lai JC, Dick AW, Hanley JM, van Meijgaard J, Setodji CM, Saigal CS. Comparative effectiveness of shock wave lithotripsy and ureteroscopy for treating patients with kidney stones. Urologic Diseases in America Project. JAMA Surg. 2014 Jul;149(7):648-53.
  30. Oshima Y, Ikematsu H, Yuji K, Tanimoto T, Tojo A. Exposure to acetaminophen and potential risk of abnormal behaviors reported in influenza and non-influenza patients. Case-control study with the Japan Adverse Drug Event Reporting. WebmedCentral HEALTH INFORMATICS. 2013 Dec 5;4(12):WMC004452.
  31. Schumock GT, Lee TA, Pickard AS, Lee W, Patel H, Dilokthornsakul P, Shoaibi A, Archdeacon P. Alternative Methods For Health Outcomes Of Interest Validation. Mini-Sentinel Methods. 2013 Aug 31;1-141.
  32. McKoy JM, Fisher MJ, Courtney DM, Raisch DW, Edwards BJ, Scheetz MH, Belknap SM, Trifilio SM, Samaras AT, Liebling DB, Nardone B, Tulas KM, West DP. Results from the first decade of research conducted by the Research on Adverse Drug Events and Reports (RADAR) project. Drug Saf. 2013 May;36(5):335-47.
  33. Ryan P, Welebob E, Hartzema AG, Stang P, Overhage JM. Surveying US observational data sources and characteristics for drug safety needs. Pharmaceutical Medicine. 2010 Aug;24(4):231-8.|A237358594&v=2.1&it=r&sid=AONE&asid=724760a7
  34. Hartzema AG, Tilson HH, Chan KA, eds. Pharmacoepidemiology and Therapeutic Risk Management. Cincinatti, OH: Harvey Whitney Books, 2008. ISBN-10: 0929375300; ISBN-13: 978-0929375304.
  35. Székács IS. Én-rendellenességek háború idején. Múlt és Jövő. 2007(3):110-115.
  36. Wikiwand: VigiBase

Website mentions:

  1. Drug consumption databases in Europe - PDF Link
  2. Drug Safety Research Unit (DSRU)
  3. International Society for Pharmacoepidemiology (ISPE)
  4. PsoBest
  5. Respiratory Effectiveness Group

Updated February 2023